GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

Combined Study - Phase 3b MenB Long Term Persistence in Adolescents

Phase 3

Completed

Conditions: Infections, Meningococcal

Interventions: Biological: rMenB+OMV NZ (Meningococcal (Group B) multi component recombinant adsorbed vaccine)

First Posted Date: 2015-05-18

Last Posted Date: 2018-11-08

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 531

Registration Number: NCT02446743

Locations: 🇨🇱
GSK Investigational Site, Santiago, Chile

Clinical Efficacy of Fluoride Toothpastes Using an In Situ Caries Model

Not Applicable

Withdrawn

Conditions: Dental Caries

Interventions: Drug: Toothpaste containing 1150ppm F
Other: Toothpaste containing 0ppm F
Drug: Toothpaste containing 250ppm F

First Posted Date: 2015-05-06

Last Posted Date: 2015-08-13

Lead Sponsor: GlaxoSmithKline

Registration Number: NCT02436473

Study Comparing Blood Levels of Fatty Acids After Consuming Two Forms of Cod Liver Oil

Not Applicable

Completed

Conditions: Growth and Development

Interventions: Other: Non-emulsified cod liver oil product
Other: Emulsified cod liver oil product

First Posted Date: 2015-04-29

Last Posted Date: 2018-08-28

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 50

Registration Number: NCT02428699

Locations: 🇬🇧
GSK Investigational Site, London, United Kingdom

Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going Children

Not Applicable

Completed

Conditions: Growth and Development

Interventions: Other: Water
Dietary Supplement: Carbohydrate beverage powder
Dietary Supplement: Calorie matched beverage powder

First Posted Date: 2015-04-28

Last Posted Date: 2018-08-31

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 30

Registration Number: NCT02428127

Locations: 🇮🇳
GSK Investigational Site, Pune, India

A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)

Phase 4

Completed

Conditions: Rhinitis, Allergic, Perennial and Seasonal
Rhinitis, Allergic

Interventions: Drug: FFNS
Other: Placebo

First Posted Date: 2015-04-23

Last Posted Date: 2021-01-11

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 358

Registration Number: NCT02424539

Locations: 🇨🇳
GSK Investigational Site, Shanghai, China

Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264

Phase 1

Completed

Conditions: Urticaria

Interventions: Drug: GSK2646264 0.5% topical cream
Drug: GSK2646264 1% topical cream
Drug: Placebo

First Posted Date: 2015-04-23

Last Posted Date: 2019-06-21

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 34

Registration Number: NCT02424799

Locations: 🇬🇧
GSK Investigational Site, London, United Kingdom

Effect of Topical Application of Iodex® Balm on Local Surface Temperature

Phase 4

Completed

Conditions: Pain

Interventions: Drug: IODEX® balm
Other: Placebo balm

First Posted Date: 2015-04-23

Last Posted Date: 2016-08-29

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 15

Registration Number: NCT02424565

Locations: 🇮🇳
GSK Investigational Site, Indiranagar, Banglador, India

Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Phase 4

Completed

Conditions: Tetanus
Poliomyelitis
Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines
Acellular Pertussis
Diphtheria